Tech Company Financing Transactions
Quantalife Funding Round
Quantalife, based in Pleasanton, raised $17.2 million from Paladin Capital Group and private investors.
Transaction Overview
Company Name
Announced On
12/13/2010
Transaction Type
Venture Equity
Amount
$17,200,000
Round
Series B
Investors
Paladin Capital Group (Paul Conley)
Proceeds Purpose
The majority of the proceeds will be used to establish commercial operations for introduction of its first product, the Droplet Digital PCR platform, into the life sciences research market early next year and accelerate development of targeted diagnostic tests.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
7068 Koll Center Parkway 401
Pleasanton, CA 94566
USA
Pleasanton, CA 94566
USA
Phone
Website
Email Address
Overview
QuantaLife, Inc. was formed to develop, manufacture and market a revolutionary nucleic acid testing concept for the Life Science Research, Clinical Molecular Diagnostics, Personalized Medical Care and Industrial markets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bill Colston
Chief Scientific Officer
Ben Hindson
VP - Bus. Development
Isaac Bright
VP - Finance
Paul Kidman
VP - Marketing
Mike Lucero
VP - Product Management
Kevin Ness
Browse more venture capital transactions:
Prev: 12/13/2010: Media6Degrees venture capital transaction
Next: 12/13/2010: Mobixell Networks venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs